X0306 4 2020-12-15 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001214133 SCHELLER RICHARD H C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 1 0 0 See Remarks Common Stock 2020-12-15 4 M 0 29277 17.00 A 167704 D Common Stock 2020-12-15 4 S 0 12091 59.806 D 155613 D Common Stock 2020-12-15 4 S 0 19352 60.7329 D 136261 D Stock Option (Right to Buy) 17.00 2020-12-15 4 M 0 29277 0.00 D 2029-06-26 Common Stock 29277 53388 D Represents the weighted average sale price of the shares sold from $59.40 to $60.39 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securuity holder of the Issuer, full information regarding the number of share sold at each separate price for all transactions as reported in footnotes 1 and 2. Represents the weighted average sale price of the shares sold from $60.40 to $61.17 per share The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date. Chairman of Research and Development /s/ Tara Condon, Attorney-in-Fact 2020-12-17